These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rebuttal to Dr Streiner: can the "evil" in the "lesser of 2 evils" be justified in placebo-controlled trials? Glass KC Can J Psychiatry; 2008 Jul; 53(7):433, discussion 434. PubMed ID: 18674399 [No Abstract] [Full Text] [Related]
6. [No new psychotropic drugs in the pipeline: psychiatry in crisis?]. Baeken C Tijdschr Psychiatr; 2013; 55(9):653-4. PubMed ID: 24046243 [No Abstract] [Full Text] [Related]
7. A half-century of participant observation in psychiatry. Part III: psychopharmacology. Rybakowski J Psychiatr Pol; 2020 Oct; 54(5):845-864. PubMed ID: 33529273 [TBL] [Abstract][Full Text] [Related]
8. Psychopharmacology of schizophrenia in children and adolescents. Carlisle LL; McClellan J Pediatr Clin North Am; 2011 Feb; 58(1):205-18, xii. PubMed ID: 21281857 [TBL] [Abstract][Full Text] [Related]
9. Ethical considerations in clinical training, care and research in psychopharmacology. Strous RD Int J Neuropsychopharmacol; 2011 Apr; 14(3):413-24. PubMed ID: 20860879 [TBL] [Abstract][Full Text] [Related]
10. Geriatric psychopharmacology: evolution of a discipline. Meyers BS; Jeste DV J Clin Psychiatry; 2010 Nov; 71(11):1416-24. PubMed ID: 21114947 [TBL] [Abstract][Full Text] [Related]
11. [Psychiatry: identity questions]. van der Meer J; van 't Hof S Tijdschr Psychiatr; 2008; 50 Spec no.():9-17. PubMed ID: 19067294 [No Abstract] [Full Text] [Related]
12. Advances in psychopharmacology--schizophrenia. Owens DG Br Med Bull; 1996 Jul; 52(3):556-74. PubMed ID: 8949257 [TBL] [Abstract][Full Text] [Related]
15. A roadmap to key pharmacologic principles in using antipsychotics: application in clinical practice. Preskorn SH J Clin Psychiatry; 2009 Apr; 70(4):593-600. PubMed ID: 19403098 [No Abstract] [Full Text] [Related]
16. [8th symposium of the Workshop for Neurospychopharmacology and Pharmacopsychiatry (AGNP) at Nuremberg, 26-29 October 1977. Pathophysiology and psychopharmacology of schizophrenic psychoses. Proceedings]. Arzneimittelforschung; 1978; 28(9):1481-538. PubMed ID: 38805 [No Abstract] [Full Text] [Related]
17. Psychopharmacology: Perspectives on medication adherence and atypical antipsychotic medications. Velligan DI; Lam F; Ereshefsky L; Miller AL Psychiatr Serv; 2003 May; 54(5):665-7. PubMed ID: 12719495 [No Abstract] [Full Text] [Related]
18. The ethics of clinical innovation in psychopharmacology: Challenging traditional bioethics. Ghaemi SN; Goodwin FK Philos Ethics Humanit Med; 2007 Nov; 2():26. PubMed ID: 17996065 [TBL] [Abstract][Full Text] [Related]
19. Bridging pharmacology and neurodevelopment in schizophrenia. Kato T Int J Neuropsychopharmacol; 2007 Dec; 10(6):713-6. PubMed ID: 17651523 [No Abstract] [Full Text] [Related]
20. Gaps in Psychiatric Training Could Challenge Delivery of Optimal Schizophrenia Pharmacotherapy. Bahji A; Bajaj N Can J Psychiatry; 2018 Feb; 63(2):146-147. PubMed ID: 29356612 [No Abstract] [Full Text] [Related] [Next] [New Search]